Glimepiride and Ticagrelor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glimepiride (glimepiride) and Ticagrelor (ticagrelor). Common drug interactions include rhabdomyolysis among females and gastric ulcer among males.

The phase IV clinical study analyzes what interactions people have when they take Glimepiride and Ticagrelor. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Glimepiride?

Glimepiride has active ingredients of glimepiride. It is often used in diabetes. eHealthMe is studying from 45,909 Glimepiride users. Check the latest studies of Glimepiride.

What is Ticagrelor?

Ticagrelor has active ingredients of ticagrelor. eHealthMe is studying from 8,499 Ticagrelor users. Check the latest studies of Ticagrelor.

On Jul, 11, 2026

43 people who take Glimepiride and Ticagrelor together, and have interactions are studied.

Glimepiride and Ticagrelor drug interactions.

What are the common drug interactions of Glimepiride and Ticagrelor, by gender? *:

female:

Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Anxiety
Asthenia (weakness)
Chronic kidney disease
Constipation
Contusion (a type of hematoma of tissue in which capillaries)
Dehydration (dryness resulting from the removal of water)
Discomfort
Dysgeusia (disorder of the sense of taste)

male:

Gastric ulcer (stomach ulcer)
Dyspnoea (difficult or laboured respiration)
Chest pain
Pancreatic carcinoma (pancreatic cancer)
Postoperative abscess
Angioplasty
Asthenia (weakness)
Atrioventricular block second degree (heart block second degree)
Blood cholesterol increased
Blood pressure increased

What are the common drug interactions of Glimepiride and Ticagrelor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Benign prostatic hyperplasia (benign enlargement of the prostate)
Blood pressure increased
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Decreased appetite
Heart rate increased
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
Venous occlusion (the blocking of venous return)

60+:

Gastric ulcer (stomach ulcer)
Dyspnoea (difficult or laboured respiration)
Renal failure (kidney dysfunction)
Chest pain
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Anxiety
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Contusion (a type of hematoma of tissue in which capillaries)
Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
Dehydration (dryness resulting from the removal of water)

What are the existing conditions these people have? *

High Blood Pressure: 18 people, 41.86%
Type 2 Diabetes: 16 people, 37.21%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 23.26%
Dyslipidaemia (abnormal amount of lipids): 8 people, 18.60%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 8 people, 18.60%
Stable Angina (a constant chest pain): 7 people, 16.28%
High Blood Cholesterol: 6 people, 13.95%
Stress And Anxiety: 4 people, 9.30%
Pain: 4 people, 9.30%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 6.98%

* Approximation only. Some reports may have incomplete information.

Do you take Glimepiride and Ticagrelor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously